Ignyta to Present at the Ladenburg Thalmann 2017 Healthcare Conference

SAN DIEGO--(BUSINESS WIRE)-- Ignyta, Inc. (Nasdaq: RXDX), a biotechnology company focused on precision medicine in oncology, announced today that Jonathan Lim, M.D., its Chairman and Chief Executive Officer, will make a presentation at the Ladenburg Thalmann 2017 Healthcare Conference on Tuesday, September 26, 2017, at 2:00 p.m. Eastern time (11:00 a.m. Pacific time) in New York, NY.

A webcast of the presentation will be available during the presentation in the Investors section of the company's website at https://www.ignyta.com/investors/, and will be archived and available at that site for 14 days.

About Ignyta, Inc.

At Ignyta, we work tirelessly on behalf of patients with cancer to offer potentially life-saving, precisely targeted therapeutics (Rx) guided by diagnostic (Dx) tests. Our integrated Rx/Dx strategy allows us to enter uncharted territory, illuminating the molecular drivers of cancer and quickly advancing treatments to address them. This approach embraces even those patients with rare cancers, who have the highest unmet need and who may otherwise not have access to effective treatment options. With our pipeline of potentially first-in-class or best-in-class precision medicines, we are pursuing the ultimate goal of not just shrinking tumors, but eradicating cancer relapse and recurrence in precisely defined patient populations.

For more information, please visit: www.ignyta.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170918005331/en/

Ignyta, Inc.
Jacob Chacko, M.D., 858-255-5959
CFO
[email protected]

Source: Ignyta, Inc.

You May Also Be Interested In

• QuickFi® Wins 2026 Finovate Award for Best SMB/SME Banking Solution
• PolarX Announces Hyper Copper Grades Over Big Widths from Surface Point to Significant Resource Growth at Caribou Dome Project
• CJ Foods' Korean Spirits Brand jari Sweeps Top Honors at Leading Global Spirits Competitions